Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,208.70
-92.35 (-4.01%)
BSENSE

May 29

BSE+NSE Vol: 3.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
-4.01%
-1.44%
1W
-4.38%
-0.85%
1M
-6.85%
-3.51%
YTD
-10.61%
-12.26%
1Y
-31.72%
-8.4%
3Y
69.79%
18.98%
5Y
44.28%
45.41%
10Y
26.25%
180.55%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.06%
2.24%
-11.82%
6 Months
-13.95%
2.28%
-11.67%
1 Year
-31.72%
1.66%
-30.06%
2 Years
-12.93%
2.65%
-10.28%
3 Years
69.79%
9.49%
79.28%
4 Years
45.38%
12.80%
58.18%
5 Years
44.28%
14.72%
59.0%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-3.27%
4
Quartile
quartile-4
Dec-Mar
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-32.97%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-3.27%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-32.97%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-3.27%
2
Quartile
quartile-2
Dec-Mar
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-32.97%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available